MedPath

A Study to estimate risk of cardiovascular disease in newly diagnosed patients of Psoriasis by utilising blood tests like Fasting Lipid Profile to calculate certain indices like the Atherogenic Index of Plasma

Not Applicable
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2023/09/057352
Lead Sponsor
IADVL Academy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Newly diagnosed cases of Psoriasis of both genders.

Exclusion Criteria

Patients suffering from psoriatic erythroderma. Patients with diseases that can cause secondary hyperlipidemia such as hypothyroidism, diabetes mellitus, nephrotic syndrome, chronic renal insufficiency, obstructive liver disease and connective tissue disorder. Patients on medications such as corticosteroids, retinoids, cyclosporin and lipid lowering agents will be excluded.Patients with diseases that can cause secondary hypolipidemia and hypoproteinemia such as malnutrition, liver failure, malabsorption syndromes, and hyperthyroidism will be excluded.

Patients with diseases that can cause secondary hyperproteinemia will also be excluded.

Patients who are unwilling to give consent to the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atherogenic Index vs Cardiovascular Risk <br/ ><br>-0.3 – 0.1Low Risk <br/ ><br>0.1 – 0.24Medium Risk <br/ ><br>0.24 High Risk <br/ ><br>Timepoint: Baseline
Secondary Outcome Measures
NameTimeMethod
ATHEROGENIC COEFFICIENT: ((Total Cholesterol-Serum HDL-c))/(HDL-c)Timepoint: Baseline;CASTELLI RISK INDEX 1: (Total Cholesterol(TC))/(HDL-c)Timepoint: Baseline;CASTELLI RISK INDEX 2: (LDL-c)/(HDL-c)Timepoint: Baseline;COMPREHENSIVE LIPID TETRAD INDEX: [total cholesterol × triglycerides × lipoprotein (a)]/high-density lipoproteinTimepoint: Baseline;FRAMINGHAM RISK SCORETimepoint: Baseline;LAP : WC-58 × TG for women LAP : WC-65 × TG for menTimepoint: Baseline
© Copyright 2025. All Rights Reserved by MedPath